The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sorafenib plus tislelizumab as maintenance therapy for patients with advanced hepatocellular carcinoma treated with transarterial chemoembolization: A phase II study.
 
Mingyue Cai
No Relationships to Disclose
 
Xiaoyang Hong
No Relationships to Disclose
 
Wensou Huang
No Relationships to Disclose
 
Yongjian Guo
No Relationships to Disclose
 
Wenbo Shi
No Relationships to Disclose
 
Licong Liang
No Relationships to Disclose
 
Jingwen Zhou
No Relationships to Disclose
 
Liteng Lin
No Relationships to Disclose
 
Ye Chen
No Relationships to Disclose
 
Kangshun Zhu
No Relationships to Disclose